NewsRoom Articles - Page 661 of 1389

TuesdayDec 10, 2019 7:40 pm

Turtle Beach Corp. (NASDAQ: HEAR) Starts Presentation at 12th Annual LD Micro Main Event

Turtle Beach (NASDAQ: HEAR) is a leading gaming audio and accessory brand, offering a wide selection of cutting-edge, award-winning gaming headsets. From professional esports athletes and hardcore gamers, to casual players and the novice, Turtle Beach has the gaming headset to help truly master any gamer’s skills. Turtle Beach products are designed for Xbox, PlayStation®, and Nintendo consoles as well as for PC, Mac®, and mobile/tablet devices. In 2019 the company acquired ROCCAT, a leading PC accessories maker that combines detail-loving German innovation with a genuine passion for designing the best PC gaming products. For more information, visit the company’s…

TuesdayDec 10, 2019 7:20 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Starts Presentation at 12th Annual LD Micro Main Event

CNS Pharmaceuticals (NASDAQ: CNSP) is a biotechnology company specializing in the development of novel treatments for primary and metastatic brain and central nervous system tumors. Its lead candidate Berubicin is for the treatment of glioblastoma, a type of brain cancer currently considered incurable, as well as pancreatic and ovarian cancers, and lymphomas. The company entered into an IP agreement with Houston Pharmaceuticals, Inc. and a purchase agreement with Reata Pharmaceuticals Inc. For more information, visit the company’s website at www.cnspharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize…

TuesdayDec 10, 2019 7:20 pm

Alpine 4 Technologies Ltd. (ALPP) Starts Presentation at 12th Annual LD Micro Main Event

Alpine 4 Technologies (OTC: ALPP) is a publicly traded enterprise with business related endeavors in software, automotive technologies, electronics manufacturing, and energy services and fabrication technologies. Alpine 4’s acquisition model is industry agnostic and is based around its “Driver, Stabilizer, Facilitator” business model. Four principles at the core of the company’s business are: synergy, innovation, drive and excellence. At Alpine 4, synergistic innovation drives excellence. By anchoring these words to its combined experience and capabilities, the company is able to aggressively pursue opportunities within and across vertical markets. For more information, visit the company’s website at www.alpine4.com. About NetworkNewsWire NetworkNewsWire…

TuesdayDec 10, 2019 7:20 pm

American Shared Hospital Services (NYSE: AMS) Starts Presentation at 12th Annual LD Micro Main Event

American Shared Hospital Services (NYSE: AMS) is a healthcare company with more than a 30-year track record of leasing state-of-the-art medical equipment to hospitals and medical centers in the United States and abroad. The company provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery equipment, a non‑invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The company also offers proton therapy, and the latest IGRT and IMRT systems. For more information, visit the company’s website at www.ashs.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

TuesdayDec 10, 2019 7:20 pm

One World Pharma Inc. (OWPC) Starts Presentation at 12th Annual LD Micro Main Event

One World Pharma (OTCQB: OWPC), through its wholly owned One World Pharma SAS subsidiary, is a fully licensed cannabis and hemp producer committed to supplying the highest quality cannabis and hemp ingredients to the world. One World Pharma was formed in 2017 to participate in the vast potential of the Colombian market created by the recent MMJ legislation of 2015 and 2017. Colombia is positioned to be a significant supplier of cannabis-based ingredients and products to the world based on its ideal climate, rich agricultural traditions, supportive legislation, and medical cannabis quotas. For more information, visit the company’s website at…

TuesdayDec 10, 2019 7:00 pm

Amarantus Bioscience Holdings Inc. (AMBS) Starts Presentation at 12th Annual LD Micro Main Event

Amarantus Bioscience (OTC: AMBS) is a JLABS alumnus biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases. The company’s lead therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia, one of the most difficult problems facing patients with Parkinson’s disease. Eltoprazine is currently in a Phase 2b clinical trial with results from the study expected in 2016. Eltoprazine is also being evaluated for the treatment of adult attention deficit hyperactivity disorder (ADHD) and Alzheimer’s aggression. For more information, visit the company’s website at www.amarantus.com. About NetworkNewsWire NetworkNewsWire…

TuesdayDec 10, 2019 7:00 pm

GI Dynamics Inc. (GIDYL) Starts Presentation at 12th Annual LD Micro Main Event

GI Dynamics (OTC: GIDYL) (ASX: GID) is the developer of EndoBarrier®, an endoscopically delivered device therapy for the treatment of Type 2 diabetes and obesity. The company’s revolutionary EndoBarrier® is a testament to the GI Dynamics mission. EndoBarrier® first endoscopically delivered device therapy for the treatment of Type 2 diabetes and obesity. EndoBarrier® is aimed to bridge the gap between pharmaceuticals and surgery by providing an alternate treatment option to help reduce HbA1c and weight for individuals who are underserved by drugs and injections, but for whom surgery is not an option. EndoBarrier® is not approved for sale and is…

TuesdayDec 10, 2019 7:00 pm

Rafael Holdings Inc. (RFL) Starts Presentation at 12th Annual LD Micro Main Event

Rafael Holdings (NYSE: RFL) includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafael's real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and an office condominium in Israel. Rafael's pharmaceutical holdings include interests in two clinical-stage oncology companies - Rafael Pharmaceuticals and LipoMedix. Rafael Pharmaceuticals is developing therapies that exploit the metabolic differences between normal cells and cancer cells in both solid and liquid cancers. LipoMedix is developing liposomal prodrugs…

TuesdayDec 10, 2019 7:00 pm

Enthusiast Gaming Holdings Inc. (TSX.V: EGLX) Starts Presentation at 12th Annual LD Micro Main Event

Enthusiast Gaming (TSX.V: EGLX) (FSE: 2AV) is building the world’s largest network of communities for gamers and esports fans. The company’s business is comprised of three main pillars: media, events and esports. The media network generates over 30 billion ad requests and over 1 billion page views per month. Enthusiast’s esports division, Luminosity Gaming, is a global esports franchise that consists of seven professional esports teams under ownership and management, including the Vancouver Titans Overwatch team and the Seattle-based Call of Duty team. Collectively, the integrated ecosystem reaches over 200 million gaming enthusiasts on a monthly basis. For more information,…

TuesdayDec 10, 2019 6:40 pm

Acerus Pharmaceuticals Corp. (TSX: ASP) (ASPCF) Starts Presentation at 12th Annual LD Micro Main Event

Acerus Pharmaceuticals (TSX: ASP) (OTCQB: ASPCF) is focused on the commercialization and development of innovative pharmaceutical products that improve the patient experience. Founded in 2008, Acerus has grown into a fully integrated, specialty pharmaceutical company with expertise in all stages of the pharmaceutical product life-cycle. The company is focused on men’s health (urology and andrology). The company’s foundational product is NATESTO®, a testosterone therapy based on patented nasal gel technology, approved in the United States, Canada and South Korea for the treatment of adult males diagnosed with hypogonadism. For more information, visit the company’s website at www.aceruspharma.com. About NetworkNewsWire NetworkNewsWire…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Turtle Beach Corp. (NASDAQ: HEAR) Starts Presentation at 12th Annual LD Micro Main Event

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Starts Presentation at 12th Annual LD Micro Main Event

Alpine 4 Technologies Ltd. (ALPP) Starts Presentation at 12th Annual LD Micro Main Event

American Shared Hospital Services (NYSE: AMS) Starts Presentation at 12th Annual LD Micro Main Event

One World Pharma Inc. (OWPC) Starts Presentation at 12th Annual LD Micro Main Event

Amarantus Bioscience Holdings Inc. (AMBS) Starts Presentation at 12th Annual LD Micro Main Event

GI Dynamics Inc. (GIDYL) Starts Presentation at 12th Annual LD Micro Main Event

Rafael Holdings Inc. (RFL) Starts Presentation at 12th Annual LD Micro Main Event

Enthusiast Gaming Holdings Inc. (TSX.V: EGLX) Starts Presentation at 12th Annual LD Micro Main Event

Acerus Pharmaceuticals Corp. (TSX: ASP) (ASPCF) Starts Presentation at 12th Annual LD Micro Main Event

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search